{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/RSPI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RSPI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPI\",,,,,undefined,":{"symbol":"RSPI","market":"US","secType":"STK","nameCN":"RespireRx Pharmaceuticals Inc.","latestPrice":0.002,"timestamp":1746475200000,"preClose":0.002,"halted":0,"volume":0,"delay":15,"floatShares":337000000,"shares":472000000,"eps":-0.012482,"marketStatus":"Not Yet Opened","change":0,"latestTime":"05-05 16:00:00 EDT Delay","open":0.002,"high":0.002,"low":0.002,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-0.012482,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746518400000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"EXPERT","adjPreClose":0.002,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"RSPI\",,,,,undefined,":{"symbol":"RSPI","floatShares":337000000,"roa":"-1104.95%","roe":"52.87%","lyrEps":-0.035688,"shares":472000000,"dividePrice":0,"high":0.002,"amplitude":0,"preClose":0.002,"low":0.002,"week52Low":0.0002,"pbRate":"-0.07","week52High":0.0069,"institutionHeld":0,"latestPrice":0.002,"eps":-0.012482,"divideRate":0,"volume":0,"delay":15,"ttmEps":-0.012482,"open":0.002,"prevYearClose":0.0008,"prevWeekClose":0.002,"prevMonthClose":0.0021,"prevQuarterClose":0.0023,"fiveDayClose":0.0021,"twentyDayClose":0.0023,"sixtyDayClose":0.001},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"RSPI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2510855076","title":"RespireRx Pharmaceuticals Inc. CFO and CEO Issue Letter to Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties","url":"https://stock-news.laohu8.com/highlight/detail?id=2510855076","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510855076?lang=en_us&edition=fundamental","pubTime":"2025-02-10 20:00","pubTimestamp":1739188800,"startTime":"0","endTime":"0","summary":"Glen Rock, N.J., Feb. 10, 2025  -- RespireRx Pharmaceuticals Inc. , a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, today provides a progress and status report to its stockholders, stakeholders, strategic partners as well as other interested parties.Dear Stockholders, Stakeholders, Strategic and Potential Strategic Partners and Other Interested Parties:. One of the things we started in 2023 and continued in January 2025 is the establishment of subsidiaries that we believe will provide substantial benefits to the Company going forward. In 2023, we established ResolutionRx Ltd as a wholly-owned Australian subsidiary to further the development of our cannabinoid program, particularly dronabinol, with a new proprietary formulation, initially for the treatment of obstructive sleep apnea. In January 2025 we converted our business unit, EndeavourRx into a wholly-owned subsidiary, EndeavourRx LL","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/respirerx-pharmaceuticals-inc-cfo-ceo-120000978.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4148","ADHD","BK4211","BDC","BK4007","RSPI","GABA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RSPI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-01-06","symbol":"RSPI","defaultRemindTime":1609943400000,"type":"split","dateTimestamp":1609909200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2019-11-15","symbol":"RSPI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1573794000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-08-15","symbol":"RSPI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1565841600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RSPI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"RSPI\",market:\"US\",delay:false,,,undefined,":{}}}